Viking Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Viking Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q2 2024.
  • Viking Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 2.94K %, a 118% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 2.94K +1.59K +118% Jun 30, 2024
Q1 2024 2.68K +1.69K +170% Mar 31, 2024
Q4 2023 2.1K +969 +85.3% Dec 31, 2023
Q3 2023 1.7K +172 +11.3% Sep 30, 2023
Q2 2023 1.35K -394 -22.6% Jun 30, 2023
Q1 2023 994 -961 -49.2% Mar 31, 2023
Q4 2022 1.14K -874 -43.5% Dec 31, 2022
Q3 2022 1.53K -435 -22.2% Sep 30, 2022
Q2 2022 1.75K -367 -17.4% Jun 30, 2022
Q1 2022 1.96K -417 -17.6% Mar 31, 2022
Q4 2021 2.01K -695 -25.7% Dec 31, 2021
Q3 2021 1.96K -1.24K -38.8% Sep 30, 2021
Q2 2021 2.11K -1.55K -42.3% Jun 30, 2021
Q1 2021 2.37K -1.84K -43.7% Mar 31, 2021
Q4 2020 2.7K -2.25K -45.5% Dec 31, 2020
Q3 2020 3.21K -2.35K -42.3% Sep 30, 2020
Q2 2020 3.66K -2.39K -39.5% Jun 30, 2020
Q1 2020 4.21K -1.53K -26.7% Mar 31, 2020
Q4 2019 4.96K +743 +17.6% Dec 31, 2019
Q3 2019 5.56K +3.25K +141% Sep 30, 2019
Q2 2019 6.06K +5.16K +578% Jun 30, 2019
Q1 2019 5.74K +5.35K +1370% Mar 31, 2019
Q4 2018 4.21K +4K +1887% Dec 31, 2018
Q3 2018 2.31K +2.11K +1056% Sep 30, 2018
Q2 2018 893 +645 +261% Jun 30, 2018
Q1 2018 391 +102 +35.4% Mar 31, 2018
Q4 2017 212 -85.1 -28.6% Dec 31, 2017
Q3 2017 200 -190 -48.7% Sep 30, 2017
Q2 2017 247 -173 -41.2% Jun 30, 2017
Q1 2017 289 -184 -39% Mar 31, 2017
Q4 2016 297 +156 +111% Dec 31, 2016
Q3 2016 390 +321 +461% Sep 30, 2016
Q2 2016 421 Jun 30, 2016
Q1 2016 473 Mar 31, 2016
Q4 2015 141 Dec 31, 2015
Q3 2015 69.6 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.